Addressing the Challenges of Clinical Research for Freezing of Gait in Parkinson's Disease

Affiliations

¹ ForeFront Parkinson's Disease Research Clinic, Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia.
² Jean and Paul Amos Parkinson's Disease and Movement Disorders Program, Emory University School of Medicine, Atlanta, Georgia, USA.
³ Movement Disorders Unit, Department of Neurology, Tel-Aviv Sourasky Medical Center, Sackler School of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
⁴ Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
⁵ Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
⁶ Movement Disorder Section, Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA.
⁷ Departments of Pathology & Cell Biology, Neurology, and Neuroscience, Columbia University, New York, New York, USA.
⁸ Department of Neurology, School of Medicine, and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.

Simon J G Lewis et al. Mov Disord. 2022 Feb.

. 2022 Feb;37(2):264-267.

doi: 10.1002/mds.28837. Epub 2021 Dec 22.

¹ ForeFront Parkinson's Disease Research Clinic, Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, New South Wales, Australia.
² Jean and Paul Amos Parkinson's Disease and Movement Disorders Program, Emory University School of Medicine, Atlanta, Georgia, USA.
³ Movement Disorders Unit, Department of Neurology, Tel-Aviv Sourasky Medical Center, Sackler School of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
⁴ Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
⁵ Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
⁶ Movement Disorder Section, Department of Neurology, Oregon Health & Science University, Portland, Oregon, USA.
⁷ Departments of Pathology & Cell Biology, Neurology, and Neuroscience, Columbia University, New York, New York, USA.
⁸ Department of Neurology, School of Medicine, and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.

No abstract available

Conflict of interest statement

Authors have no conflict of interest with the present manuscript.

1. Bohnen NI, Costa RM, Dauer W, et al. Discussion of research priorities for gait disorders in Parkinson’s disease. Mov Disord 2021;Under Review. - PMC - PubMed
1. Avila C, Kucinski A, Sarter M. Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons. J Neurosci 2020;40(31):6049–6067. - PMC - PubMed
1. Revuelta GJ, Uthayathas S, Wahlquist AE, Factor SA, Papa SM. Non-human primate FOG develops with advanced parkinsonism induced by MPTP Treatment. Exp Neurol 2012;237(2):464–469. - PMC - PubMed
1. Sarter M, Avila C, Kucinski A, Donovan E. Make a Left Turn: Cortico-Striatal Circuitry Mediating the Attentional Control of Complex Movements. Mov Disord 2021;36(3):535–546. - PMC - PubMed
1. Wilson J, Yarnall AJ, Craig CE, et al. Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson’s Disease. Movement disorders : official journal of the Movement Disorder Society 2021;36(3):611–621. - PMC - PubMed